The present application is generally directed to compositions comprising a bioactive lipid, a stabilizing agent, a solution, and ethanol. Methods associated with the preparation and use of such compositions, for example, for treating, preventing, or reversing diabetic retinopathy, age-related macular degeneration, retinopathy of prematurity in children, or diabetic macular edema in a subject in need thereof, are also provided.
